Cargando…
Conferring liver selectivity to a thyromimetic using a novel nanoparticle increases therapeutic efficacy in a diet-induced obesity animal model
Optimization of metabolic regulation is a promising solution for many pathologies, including obesity, dyslipidemia, type 2 diabetes, and inflammatory liver disease. Synthetic thyroid hormone mimics–based regulation of metabolic balance in the liver showed promise but was hampered by the low biocompa...
Autores principales: | Wu, Ruiling, Prachyathipsakul, Theeraphop, Zhuang, Jiaming, Liu, Hongxu, Han, Yanhui, Liu, Bin, Gong, Shuai, Qiu, Jingyi, Wong, Siu, Ribbe, Alexander, Medeiros, Jewel, Bhagabati, Jayashree, Gao, Jingjing, Wu, Peidong, Dutta, Ranit, Herrera, Roman, Faraci, Steve, Xiao, Hang, Thayumanavan, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465086/ https://www.ncbi.nlm.nih.gov/pubmed/37649581 http://dx.doi.org/10.1093/pnasnexus/pgad252 |
Ejemplares similares
-
Thyromimetics: What does the future hold?
por: Unnikrishnan, A. G., et al.
Publicado: (2012) -
Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease
por: Kowalik, Marta A., et al.
Publicado: (2018) -
Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2021) -
Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis?
por: Sinha, Rohit A., et al.
Publicado: (2020) -
Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease
por: Zhao, Man, et al.
Publicado: (2022)